학술논문
Bendamustine-bortezomib-dexamethasone (BVD) in heavily pretreated multiple myeloma: old/new in novel agents’ era
Document Type
Abstract
Author
Source
In Hematology, Transfusion and Cell Therapy October 2020 42 Supplement 1:22-22
Subject
Language
ISSN
2531-1379